Skip to main content
. 2011 Oct 13;16(6):430–443. doi: 10.3109/13625187.2011.614029

Figure 5.

Figure 5

(A) Prevalence (%) of acne and (B) changes in acne severity (%) from baseline to last measurement during treatment with NOMAC/E2 (grey bars) and DRSP/EE (black bars). NOMAC, nomegestrol acetate; E2, oestradiol; EE, ethinylestradiol; DRSP drospirenone; LM, last measurement.